"Another factor that has driven the growth of immunoassay systems market is the ongoing technology innovations. New technologies for immunoassays are addressing key un-met needs in accuracy, cost, sensitivity and diagnostic speed".
"Key unmet market needs have also encouraged diagnostic companies like Abbott, Siemens, Roche, Biorad, Beckman Coulter, bioM?rieux etc., to develop novel assays, and differentiate themselves from others in order to stay ahead of the competition in the market".
ADO Price at posting:
7.6¢ Sentiment: Buy Disclosure: Held
